NCT02581852

Brief Summary

This study compares workability in subjects with seropositive rheumatoid arthritis (RA) in the working age with high and low disease activity. Further interest is to clarify the influence of frailty, functional ability and muscle strength on workability and to determine the effect of disease activity on selected physiological needs (sleep quality, sexual functioning). Methods include a physical examination, questionnaires and physical tests.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 21, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

March 6, 2017

Status Verified

March 1, 2017

Enrollment Period

10 months

First QC Date

July 10, 2015

Last Update Submit

March 3, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Workability

    Self-reported work ability will be measured by the work ability index (WAI). The WAI is a questionnaire consisting of seven subscales: current work ability compared with the lifetime best; work ability in relation to the demands of the job; number of current diseases diagnosed by a physician; estimated work impairment due to disease; sick leave during the past 12 month; own prognosis of work ability 2 years from now; and mental resources. The cumulative index of WAI ranges from 7 to 49 points. It is then divided into 4 categories: poor (7-27 points), moderate (28-36 points), good (37-43 points) and excellent work ability (44-49 points).

    Day 1

Secondary Outcomes (7)

  • Functional Disability

    Day 1

  • Frailty

    Day 1

  • Lower-extremity function

    Day 1

  • Musculus quadriceps femoris strength

    Day1

  • Hand grip strength

    Day1

  • +2 more secondary outcomes

Other Outcomes (3)

  • IL-6

    Day1

  • TNF-alpha

    Day1

  • CRP

    Day 1

Study Arms (1)

Single arm assessment

OTHER

Cross sectional assessment of workability, functional disability, frailty, muscle strength, quality of sleep and sexual functioning of rheumatoid arthritis patients with different disease activity levels.

Other: Cross sectional assessment

Interventions

Assessment of workability, functional disability, frailty, muscle strength, quality of sleep and sexual functioning

Single arm assessment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Seropositive rheumatoid arthritis according to EULAR Criteria
  • Age ≥18 and ≤65 years

You may not qualify if:

  • Cannot understand questionnaires in the languages provided (German , English, Turkish, Serb o-Croatian)
  • Cannot understand instructions for physical tests/assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Berner C, Erlacher L, Quittan M, Fenzl KH, Dorner TE. Workability and Muscle Strength in Patients With Seropositive Rheumatoid Arthritis: Survey Study Protocol. JMIR Res Protoc. 2017 Mar 2;6(3):e36. doi: 10.2196/resprot.6449.

Study Officials

  • Thomas Dorner, Assoc Prof, MD, MPH

    Institute of Social Medicine and Centre of Public Health

    STUDY CHAIR
  • Ludwig Erlacher, Prof. MD

    Kaiser Franz Josefs Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Ludwig Erlacher

Study Record Dates

First Submitted

July 10, 2015

First Posted

October 21, 2015

Study Start

October 1, 2015

Primary Completion

August 1, 2016

Study Completion

November 1, 2016

Last Updated

March 6, 2017

Record last verified: 2017-03